Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia
Globe Newswire23-09-2024, 12:00
Veloce CPQ Acknowledged for Best Functionality in CPQ Vendor Assessment 11-01-2023, 04:31